Introduction: Human papillomavirus (HPV) infection remains the most common cause of
cervical intraepithelial neoplasia. The objective of this study is to evaluate
the sensitivity and predictive value of the HPV test associated with the
cervico-uterine smear in the screening of cervical intraepithelial neoplasia in
our environment. Methodology: This is a descriptive cross-sectional
study of 625 women who consulted in the department of gynecology for cervical
cancer screening, of whom 300 received an HPV test; during the period from
January the 1st to December 31st, 2018 at Panzi general reference hospital(South-Kivu, DRC). Data analysis was done using Epi Info version 7 software. Results: For all respondents (n=625), the cervico-uterine
smear was normal in 82.88%, inflammatory in 2.4% of cases and with cellular
atypia in 14.72%. The HPV test was positive in 87 respondents against 213
negatives cases, i.e. a prevalence of
HPV of 29% [95% CI: 23.9% - 34.5%]. Among women with precancerous lesions,
27.6% had HPV infection; among those with normal smears, 29.3% of them had HPV
infection; however, this difference was not statistically significant. Patients
with dysplastic lesions, 31.3% had genotypes with very high carcinogenic potential;
and for those with a normal Pap smear, 45.1% had genotypes with very high
carcinogenic potential; however, this difference was also not statistically
significant. Conclusion: The human papillomavirus test remains a very
important indication cation in the detection of cervical intraepithelial
neoplasia, its sensitivity remaining clearly superior to that of cytology,
especially for high grade lesions.
References
[1]
Grce, M. and Davies, P. (2008) Human Papillomavirus Testing for Primary Cervical Cancer Screening. Expert Review of Molecular Diagnostics, 8, 599-605.
https://doi.org/10.1586/14737159.8.5.599
[2]
Effah, K., Amua, J.E., Dunyo, P., Akwada, G., Kalmoni, Y., Wormenor, C.M., et al. (2021) Raising Funds through Social Media to Subsidise Cervical Cancer Screening with HPV Testing in Rural Ghana—The Battor Experience. Journal of Health Care for the Poor and Underserved, 53, 1689-1699.
https://doi.org/10.1353/hpu.2021.0118
[3]
Esagoff, A., Cohen, S.A., Chang, G., Equils, O. and Van Orman, S. (2021) Human Papillomavirus and Chinese International Students in the United States: Attitudes, Knowledge, Vaccination Trends, Healthcare Behaviors, and Sexual Activity. Human Vaccines & Immunotherapeutics, 1-12.
https://doi.org/10.1080/21645515.2021.1882283
[4]
Zhu, Y., Wang, Y., Hirschhorn, J., Welsh, K.J., Zhao, Z., Davis, M.R., et al. (2017) Human Papillomavirus and Its Testing Assays, Cervical Cancer Screening, and Vaccination. In: Advances in Clinical Chemistry, Vol. 81, Elsevier Inc., Amsterdam, 135-192. https://doi.org/10.1016/bs.acc.2017.01.004
[5]
Castanon, A., Landy, R. and Sasieni, P. (2013) How Much Could Primary Human Papillomavirus Testing Reduce Cervical Cancer Incidence and Morbidity? Journal of Medical Screening, 20, 99-103. https://doi.org/10.1177/0969141313492313
[6]
Horn, J., Denecke, A., Luyten, A., Rothe, B., Reinecke-Lüthge, A., Mikolajczyk, R., et al. (2019) Reduction of Cervical Cancer Incidence within a Primary HPV Screening Pilot Project (WOLPHSCREEN) in Wolfsburg, Germany. British Journal of Cancer, 120, 1015-1022. https://doi.org/10.1038/s41416-019-0453-2
[7]
Blanc, B. (2005) Le dépistage du cancer du col de l’utérus. Springer Verlag, Berlin, 180.
[8]
Fernandez, H. (2005) Traité de gynécologie. Flammarion. 350-358.
[9]
Wang, J.J., Lyu, L.P., Hu, Q.W., Wan, Z.Q., Dong, J., Pan, M., et al. (2017) A Proper Triage for Detecting Women with High-Risk Human Papillomavirus Genotypes Other than HPV16/18. Journal of Obstetrics & Gynecology and Reproductive Biology, 219, 113-118. https://doi.org/10.1016/j.ejogrb.2017.10.021
[10]
Kasap, B., Yetimalar, H., Keklik, A., Yildiz, A., Cukurova, K. and Soylu, F. (2011) Prevalence and Risk Factors for Human Papillomavirus DNA in Cervical Cytology. Journal of Obstetrics & Gynecology and Reproductive Biology, 159, 168-171.
https://doi.org/10.1016/j.ejogrb.2011.06.021
[11]
Garbuglia, A.R., Piselli, P., Lapa, D., Sias, C., Del Nonno, F., Baiocchini, A., et al. (2012) Frequency and Multiplicity of Human Papillomavirus Infection in HIV-1 Positive Women in Italy. Journal of Clinical Virology, 54, 141-146.
https://doi.org/10.1016/j.jcv.2012.02.013
[12]
Corrêa, C.M., Teixeira, N.C.P., Araújo, A.C.L., Carvalho, N.O., Castillo, D.M., Campos, R.R., et al. (2011) Prevalence and Multiplicity of HPV in HIV Women in Minas Gerais, Brazil. Revista da Associação Médica Brasileira, 57, 418-423.
http://www.ncbi.nlm.nih.gov/pubmed/21876925
https://doi.org/10.1016/S2255-4823(11)70088-1
[13]
Agaba, P.A., Thacher, T.D., Ekwempu, C.C. and Idoko, J.A. (2009) Cervical Dysplasia in Nigerian Women Infected with HIV. International Journal of Gynecology & Obstetrics, 107, 99-102. https://doi.org/10.1016/j.ijgo.2009.06.006
[14]
Takamatsu, R., Nabandith, V., Pholsena, V., Mounthisone, P., Nakasone, K., Ohtake, K., et al. (2017) Cervical Cytology and Human Papillomavirus among Asymptomatic Healthy Volunteers in Vientiane, Lao PDR. BMC Cancer, 17, 872.
https://doi.org/10.1186/s12885-017-3900-6
[15]
Mutombo, A.B., Benoy, I., Tozin, R. and Bogers, J. (2019) Prevalence and Distribution of Human Papillomavirus Genotypes among Women in Kinshasa, The Democratic Republic of the Congo. 1-9. https://doi.org/10.1200/JGO.19.00110
[16]
Traoré, I.M.A., Zohoncon, T.M., Dembele, A., Djigma, F.W., Obiri-yeboah, D., Traore, G., et al. (2016) Molecular Characterization of High-Risk Human Papillomavirus in Women in Bobo-Dioulasso, Burkina Faso. BioMed Research International, 2016, Article ID: 7092583. https://doi.org/10.1155/2016/7092583
[17]
Kightlinger, R.S., Irvin, W.P., Archer, K.J., Huang, N.W., Wilson, R.A., Doran, J.R., et al. (2010) Cervical Cancer and Human Papillomavirus in Indigenous Guyanese Women. American Journal of Obstetrics & Gynecology, 202, 626.e1-7.
https://doi.org/10.1016/j.ajog.2010.03.015
[18]
Dunne, E.F., Unger, E.R., et al. (2007) Prevalence of HPV Infection among Females in the United States. Journal of the American Medical Association, 297, 813-819.
https://doi.org/10.1001/jama.297.8.813
[19]
Matos, E., Loria, D., Amestoy, G.M., Herrera, L., Prince, M.A., Moreno, J., et al. (2003) Prevalence of Human Papillomavirus Infection among Women in Concordia, Argentina: A Population-Based Study. Sexually Transmitted Diseases, 30, 593-599.
[20]
Sowjanya, A.P., Jain, M., Poli, U.R., Padma, S., Das, M., Shah, K.V., et al. (2005) Prevalence and Distribution of High-Risk Human Papilloma Virus (HPV) Types in Invasive Squamous Cell Carcinoma of the Cervix and in Normal Women in Andhra Pradesh, India. BMC Infectious Diseases, 5, 116.
https://doi.org/10.1186/1471-2334-5-116
[21]
Wang, J., Tang, D., Wang, J., Zhang, Z., Chen, Y., Wang, K., et al. (2019) Genotype Distribution and Prevalence of Human Papillomavirus among Women with Cervical Cytological Abnormalities in Xinjiang, China. Human Vaccines & Immunotherapeutics, 15, 1889-1896.
[22]
García-Espinosa, B., Nieto-Bona, M.P., Rueda, S., Silva-Snchez, L.F., Piernas-Morales, M.C., Carro-Campos, P., et al. (2009) Genotype Distribution of Cervical Human Papillomavirus DNA in Women with Cervical Lesions in Bioko, Equatorial Guinea. Diagnostic Pathology, 4, 31. https://doi.org/10.1186/1746-1596-4-31
[23]
Keita, N., Clifford, G.M., Koulibaly, M., Douno, K., Kabba, I., Haba, M., et al. (2009) HPV Infection in Women with and without Cervical Cancer in Conakry, Guinea. British Journal of Cancer, 101, 202-208. https://doi.org/10.1038/sj.bjc.6605140
[24]
Vuyst, H.D.E., Steyaert, S., Renterghem, L.V.A.N., Claeys, P., Muchiri, L., Path, M., et al. (2003) Distribution of Human Papillomavirus in a Family Planning Population in Nairobi, Kenya. Sexually Transmitted Diseases, 30, 137-142.
https://doi.org/10.1097/00007435-200302000-00009
[25]
Akarolo-anthony, S.N., Famooto, A.O., Dareng, E.O., Olaniyan, O.B., Offiong, R., Wheeler, C.M., et al. (2014) Age-Specific Prevalence of Human Papilloma Virus Infection among Nigerian Women. BMC Public Health, 14, 656.
https://doi.org/10.1186/1471-2458-14-656
[26]
Flanagan, M.B. (2018) Primary High-Risk Human Papillomavirus Testing for Cervical Cancer Screening in the United States: Is It Time? Archives of Pathology & Laboratory Medicine, 142, 688-692. https://doi.org/10.5858/arpa.2018-0001-RA
